Results from Upadacitinib Phase 3 SELECT-MONOTHERAPY Study Published in The Lancet
Medical Health News,
— AbbVie (NYSE: ABBV), a global biopharmaceutical company, today announced the publication of positive results from the pivotal…
— AbbVie (NYSE: ABBV), a global biopharmaceutical company, today announced the publication of positive results from the pivotal…
— AbbVie (NYSE: ABBV), a global biopharmaceutical company, today announced the publication of positive results from the pivotal…
SELECT-MONOTHERAPY evaluates the safety and efficacy of upadacitinib monotherapy in adult patients with moderately to severely…